MedTrace Logo

Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study

NCT02186041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2021-07-16

No results posted yet for this study

Summary

The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy for up to 5 years in a representative sample of French centers under real-life conditions of use.

Conditions

Interventions

DEVICE

Sacral Nerve Modulation

Sponsors & Collaborators

  • Medtronic France SAS

    collaborator INDUSTRY

  • MedtronicNeuro

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2021-03-22
Completion
2021-03-22

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02186041 on ClinicalTrials.gov